NiclosaMide-13C6 hydrate (see Data Sheet) structure
|
Common Name | NiclosaMide-13C6 hydrate (see Data Sheet) | ||
---|---|---|---|---|
CAS Number | 1325808-64-7 | Molecular Weight | 333.076 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C713C6H8Cl2N2O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of NiclosaMide-13C6 hydrate (see Data Sheet)Niclosamide-13C6 is the 13C6 labeled Niclosamide. Niclosamide (BAY2353) is an orally bioavailable chlorinated salicylanilide, with anthelmintic and potential antineoplastic activity. Niclosamide (BAY2353) inhibits STAT3 with IC50 of 0.25 μM in HeLa cells and inhibits DNA replication in a cell-free assay. |
Name | 5-Chloro-N-[2-chloro-4-nitro(13C6)phenyl]-2-hydroxybenzamide |
---|---|
Synonym | More Synonyms |
Description | Niclosamide-13C6 is the 13C6 labeled Niclosamide. Niclosamide (BAY2353) is an orally bioavailable chlorinated salicylanilide, with anthelmintic and potential antineoplastic activity. Niclosamide (BAY2353) inhibits STAT3 with IC50 of 0.25 μM in HeLa cells and inhibits DNA replication in a cell-free assay. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Molecular Formula | C713C6H8Cl2N2O4 |
Molecular Weight | 333.076 |
Exact Mass | 332.006256 |
Index of Refraction | 1.709 |
5-Chloro-N-[2-chloro-4-nitro(13C6)phenyl]-2-hydroxybenzamide |
Benzamide, 5-chloro-N-(2-chloro-4-nitrophenyl-1,2,3,4,5,6-13C6)-2-hydroxy- |